Multinational Glanzmann Study

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 1, 2028

Study Completion Date

March 1, 2029

Conditions
Glanzmann Thrombasthenia
All Listed Sponsors
lead

UMC Utrecht

OTHER

NCT06204042 - Multinational Glanzmann Study | Biotech Hunter | Biotech Hunter